MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Avalyn Pharma, formerly, Genoa Pharmaceuticals (ALVN)
Finance & Acquisition: Avalyn Pharma
Parents
Avalyn Pharma, formerly, Genoa Pharmaceuticals (ALVN)
Children
2025: Avalyn raises $100M to advance inhaled versions of approved lung disease meds
2025: The company’s series D fundraise was led by Suvretta Capital Management and SR One and included 16 other investors, such as Novo Holdings, the investor fund best known as the controlling shareholder of Novo Nordisk.
2026: Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline
Jumps
Key People: Avalyn Pharma
Organization & Developments: Avalyn Pharma